Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Medical Research

The Regulatory Trilemma of Medical AI: A New Framework for Navigating Innovation, Rights, and Sovereignty in Global Governance

View Full Paper
Ask AI
Bookmark
Share

Authors

CLChangkui LIApplied Science and Technology Research Institute

Discussion

Loading...

Member takes

Overview

This framework reveals trade-offs in global governance of medical AI, highlighting innovation and rights issues.

Key Points

  • The proposed framework illustrates systemic trade-offs among innovation, rights protection, and sovereignty.
  • Case studies show the US prioritizes innovation speed, while the EU focuses on rights and safety.
  • China’s approach emphasizes sovereignty through state-led data control, leading to global market fragmentation.
  • These divergent regulatory paths complicate standard-setting and threaten health equity across nations.

Cite This Study

Changkui LI (2025) studied this question.

synapsesocial.com/papers/68c1954e9b7b07f3a0618a4dhttps://doi.org/10.6913/mrhk.070301
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Innovation-Regulation Trade-off: Navigating Rapid Artificial Intelligence Advancements Within Evolving Compliance Boundaries2026
  2. 2Implications of the new US AI framework in medicine2026
  3. 3The Governance Vacuum in Medical Device AI: Toward an Equitable and Accountable Framework2025
  4. 4The Governance Vacuum in Medical Device AI: Toward an Equitable and Accountable Framework2025
  5. 5Triadic Contest: The US, China, EU, and the Battle for the Soul of AI2026